Moderators:

Helen Burstin, MD, MPH, MACP, Chief Executive Officer, Council of Medical Specialty Societies

Tod Ibrahim, Executive Vice President, American Society of Nephrology

The goal of this session is to identify the following:

• What are the most effective strategies to develop and test clinical algorithms prior to widespread implementation?
• How can we mitigate disparities and drive implementation of revised algorithms for diagnosis and treatment in clinical practice?
• What data resources and funding are required to identify and assess algorithms that require further research, testing, dissemination, and implementation?
• How can diverse stakeholders (e.g., clinicians, specialty societies, patients, government, labs, vendors) align strategies to de-implement harmful algorithms that may be entrenched in clinical practice, workflow, payment, or existing systems?